Compare Revvity Inc (RVTY) vs Invesco Solar ETF (TAN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Invesco Solar ETF — how do they compare? Revvity Inc trades at $116.28 (market cap $12.91B), while Invesco Solar ETF trades at $52.46. The key difference: Revvity Inc pays a 0.24% dividend while Invesco Solar ETF pays none, and Revvity Inc is trading nearer its 52-week high, Invesco Solar ETF nearer its low. Which is the better fit depends on your goals.
| RVTY | TAN | |
|---|---|---|
Market Cap | $12.91B | — |
Sector | Technology | Sector/Thematic |
52-Week High | $117.75 | $73.95 |
52-Week Low | $82.26 | $36.62 |
Enterprise Value | $15.23B | — |
Dividend Yield | 0.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $116.10, up 0.07% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The company reported Q2 2026 EPS of $1.41, surpassing the $1.21 estimate, and raised its full-year outlook due to robust diagnostics demand. Revenue remains steady around $2.9 billion, with a net income margin of 8.16%. Analyst consensus is a Buy with a $120.50 price target, and recent news highlights product launches like the SuperFlex prenatal system and high-throughput TB testing platform.
The outlook for RVTY is positive, supported by earnings momentum and strategic innovations, but investors face risks from high valuation multiples and competitive pressures in the healthcare sector. The stock's proximity to its consensus target suggests limited near-term upside, requiring careful monitoring of execution against raised guidance.
TAN trades at $52.41, up 1.06% in the last session, amid a bearish technical signal with selling pressure outweighing buys 11 to 4. Recent news highlights solar sector volatility and policy impacts, including new polysilicon tariffs under the Trump administration that may reshape U.S. solar manufacturing dynamics. The ETF's high beta of 1.41 indicates elevated sensitivity to market swings compared to broader energy funds.
Outlook is mixed: tariffs could boost U.S.-focused solar stocks but face headwinds from permit delays and weak residential demand. Risks include regulatory uncertainty and competition from nuclear energy. Analyst sentiment is cautious, with downgrades citing valuation and technical deterioration, though long-term growth drivers like AI energy demand persist.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Invesco Solar ETF
TAN is a thematic ETF that tracks the MAC Global Solar Energy Index. It provides targeted exposure to the global solar industry, including manufacturers of solar panels, installers, and component suppliers like Enphase and First Solar.
Read more on TAN →
